APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cancer Biopsy Instruments and Kits

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cancer Biopsy Instruments and Kits Market Analysis and Forecast 2026-2032

Report ID 17442326045 July 2026195 pages

Choose your research edition.

Industry ResearchCancer Biopsy Instruments and Kits Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Biopsy Instruments and Kits Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Cancer Biopsy Instruments and Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Biopsy Instruments and Kits Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Biopsy Instruments and Kits Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Cancer Biopsy Instruments and Kits market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cancer Biopsy Instruments and Kits is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cancer Biopsy Instruments and Kits is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cancer Biopsy Instruments and Kits is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cancer Biopsy Instruments and Kits is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Cancer Biopsy Instruments and Kits include QIAGEN NV, ANGLE plc, Becton, Dickinson and Company, BIOCEPT, INC., Danaher Corporation, Hologic, Inc., Illumina, Inc., Lucence Diagnostics Pte. Ltd. and Myriad Genetics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cancer Biopsy Instruments and Kits, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cancer Biopsy Instruments and Kits, also provides the sales of main regions and countries. Of the upcoming market potential for Cancer Biopsy Instruments and Kits, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cancer Biopsy Instruments and Kits sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cancer Biopsy Instruments and Kits market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cancer Biopsy Instruments and Kits sales, projected growth trends, production technology, application and end-user industry.

Cancer Biopsy Instruments and Kits Segment by Company

QIAGEN NV

ANGLE plc

Becton, Dickinson and Company

BIOCEPT, INC.

Danaher Corporation

Hologic, Inc.

Illumina, Inc.

Lucence Diagnostics Pte. Ltd.

Myriad Genetics

Thermo Fisher Scientific, Inc.

Cancer Biopsy Instruments and Kits Segment by Type

Cancer Biopsy Instruments

Cancer Biopsy Kits

Cancer Biopsy Instruments and Kits Segment by Application

Breast Cancer

Colorectal Cancer

Cervical Cancer

Lung Cancer

Others

Cancer Biopsy Instruments and Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Biopsy Instruments and Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Biopsy Instruments and Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Biopsy Instruments and Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Cancer Biopsy Instruments and Kits in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Cancer Biopsy Instruments and Kits manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Biopsy Instruments and Kits sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cancer Biopsy Instruments and Kits Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cancer Biopsy Instruments Major Manufacturers Table 3. Cancer Biopsy Kits Major Manufacturers Table 4. Global Cancer Biopsy Instruments and Kits Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Breast Cancer Major Manufacturers Table 6. Colorectal Cancer Major Manufacturers Table 7. Cervical Cancer Major Manufacturers Table 8. Lung Cancer Major Manufacturers Table 9. Others Major Manufacturers Table 10. Cancer Biopsy Instruments and Kits Industry Trends Table 11. Cancer Biopsy Instruments and Kits Industry Drivers Table 12. Cancer Biopsy Instruments and Kits Industry Opportunities and Challenges Table 13. Cancer Biopsy Instruments and Kits Industry Restraints Table 14. Global Cancer Biopsy Instruments and Kits Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Cancer Biopsy Instruments and Kits Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Cancer Biopsy Instruments and Kits Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Region (2021-2026) Table 18. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Region (2027-2032) Table 19. Global Cancer Biopsy Instruments and Kits Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Cancer Biopsy Instruments and Kits Sales by Region (2021-2026) & (k units) Table 21. Global Cancer Biopsy Instruments and Kits Sales by Region (2027-2032) & (k units) Table 22. Global Cancer Biopsy Instruments and Kits Sales Market Share by Region (2021-2026) Table 23. Global Cancer Biopsy Instruments and Kits Sales Market Share by Region (2027-2032) Table 24. Global Cancer Biopsy Instruments and Kits Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Cancer Biopsy Instruments and Kits Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Cancer Biopsy Instruments and Kits Sales Market Share by Manufacturers (2021-2026) Table 28. Global Cancer Biopsy Instruments and Kits Sales Price (USD/unit) of Manufacturers (2021-2026) Table 29. Global Cancer Biopsy Instruments and Kits Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Cancer Biopsy Instruments and Kits Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Cancer Biopsy Instruments and Kits Manufacturers, Product Type & Application Table 32. Global Cancer Biopsy Instruments and Kits Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Cancer Biopsy Instruments and Kits by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Cancer Biopsy Instruments and Kits Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Cancer Biopsy Instruments and Kits Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Cancer Biopsy Instruments and Kits Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2021-2026) Table 39. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2027-2032) Table 40. Global Cancer Biopsy Instruments and Kits Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 42. Global Cancer Biopsy Instruments and Kits Sales by Type (2027-2032) & (k units) Table 43. Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2021-2026) Table 44. Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2027-2032) Table 45. Global Cancer Biopsy Instruments and Kits Price by Type (2021-2026) & (USD/unit) Table 46. Global Cancer Biopsy Instruments and Kits Price by Type (2027-2032) & (USD/unit) Table 47. Global Cancer Biopsy Instruments and Kits Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Cancer Biopsy Instruments and Kits Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Cancer Biopsy Instruments and Kits Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2021-2026) Table 51. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2027-2032) Table 52. Global Cancer Biopsy Instruments and Kits Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 54. Global Cancer Biopsy Instruments and Kits Sales by Application (2027-2032) & (k units) Table 55. Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2021-2026) Table 56. Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2027-2032) Table 57. Global Cancer Biopsy Instruments and Kits Price by Application (2021-2026) & (USD/unit) Table 58. Global Cancer Biopsy Instruments and Kits Price by Application (2027-2032) & (USD/unit) Table 59. QIAGEN NV Company Information Table 60. QIAGEN NV Business Overview Table 61. QIAGEN NV Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 62. QIAGEN NV Cancer Biopsy Instruments and Kits Product Portfolio Table 63. QIAGEN NV Recent Development Table 64. ANGLE plc Company Information Table 65. ANGLE plc Business Overview Table 66. ANGLE plc Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. ANGLE plc Cancer Biopsy Instruments and Kits Product Portfolio Table 68. ANGLE plc Recent Development Table 69. Becton, Dickinson and Company Company Information Table 70. Becton, Dickinson and Company Business Overview Table 71. Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Portfolio Table 73. Becton, Dickinson and Company Recent Development Table 74. BIOCEPT, INC. Company Information Table 75. BIOCEPT, INC. Business Overview Table 76. BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Portfolio Table 78. BIOCEPT, INC. Recent Development Table 79. Danaher Corporation Company Information Table 80. Danaher Corporation Business Overview Table 81. Danaher Corporation Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Danaher Corporation Cancer Biopsy Instruments and Kits Product Portfolio Table 83. Danaher Corporation Recent Development Table 84. Hologic, Inc. Company Information Table 85. Hologic, Inc. Business Overview Table 86. Hologic, Inc. Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Hologic, Inc. Cancer Biopsy Instruments and Kits Product Portfolio Table 88. Hologic, Inc. Recent Development Table 89. Illumina, Inc. Company Information Table 90. Illumina, Inc. Business Overview Table 91. Illumina, Inc. Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Illumina, Inc. Cancer Biopsy Instruments and Kits Product Portfolio Table 93. Illumina, Inc. Recent Development Table 94. Lucence Diagnostics Pte. Ltd. Company Information Table 95. Lucence Diagnostics Pte. Ltd. Business Overview Table 96. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Portfolio Table 98. Lucence Diagnostics Pte. Ltd. Recent Development Table 99. Myriad Genetics Company Information Table 100. Myriad Genetics Business Overview Table 101. Myriad Genetics Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Myriad Genetics Cancer Biopsy Instruments and Kits Product Portfolio Table 103. Myriad Genetics Recent Development Table 104. Thermo Fisher Scientific, Inc. Company Information Table 105. Thermo Fisher Scientific, Inc. Business Overview Table 106. Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Portfolio Table 108. Thermo Fisher Scientific, Inc. Recent Development Table 109. North America Cancer Biopsy Instruments and Kits Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Cancer Biopsy Instruments and Kits Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 112. North America Cancer Biopsy Instruments and Kits Sales by Type (2027-2032) & (k units) Table 113. North America Cancer Biopsy Instruments and Kits Sales Price by Type (2021-2026) & (USD/unit) Table 114. North America Cancer Biopsy Instruments and Kits Sales Price by Type (2027-2032) & (USD/unit) Table 115. North America Cancer Biopsy Instruments and Kits Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Cancer Biopsy Instruments and Kits Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 118. North America Cancer Biopsy Instruments and Kits Sales by Application (2027-2032) & (k units) Table 119. North America Cancer Biopsy Instruments and Kits Sales Price by Application (2021-2026) & (USD/unit) Table 120. North America Cancer Biopsy Instruments and Kits Sales Price by Application (2027-2032) & (USD/unit) Table 121. North America Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. North America Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. North America Cancer Biopsy Instruments and Kits Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 125. North America Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 126. North America Cancer Biopsy Instruments and Kits Sales by Country (2027-2032) & (k units) Table 127. North America Cancer Biopsy Instruments and Kits Sales Price by Country (2021-2026) & (USD/unit) Table 128. North America Cancer Biopsy Instruments and Kits Sales Price by Country (2027-2032) & (USD/unit) Table 129. United States Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 130. Canada Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 131. Mexico Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 132. Europe Cancer Biopsy Instruments and Kits Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe Cancer Biopsy Instruments and Kits Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 135. Europe Cancer Biopsy Instruments and Kits Sales by Type (2027-2032) & (k units) Table 136. Europe Cancer Biopsy Instruments and Kits Sales Price by Type (2021-2026) & (USD/unit) Table 137. Europe Cancer Biopsy Instruments and Kits Sales Price by Type (2027-2032) & (USD/unit) Table 138. Europe Cancer Biopsy Instruments and Kits Revenue by Application (2021-2026) & (US$ Million) Table 139. Europe Cancer Biopsy Instruments and Kits Revenue by Application (2027-2032) & (US$ Million) Table 140. Europe Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 141. Europe Cancer Biopsy Instruments and Kits Sales by Application (2027-2032) & (k units) Table 142. Europe Cancer Biopsy Instruments and Kits Sales Price by Application (2021-2026) & (USD/unit) Table 143. Europe Cancer Biopsy Instruments and Kits Sales Price by Application (2027-2032) & (USD/unit) Table 144. Europe Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Europe Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Europe Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Europe Cancer Biopsy Instruments and Kits Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 148. Europe Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 149. Europe Cancer Biopsy Instruments and Kits Sales by Country (2027-2032) & (k units) Table 150. Europe Cancer Biopsy Instruments and Kits Sales Price by Country (2021-2026) & (USD/unit) Table 151. Europe Cancer Biopsy Instruments and Kits Sales Price by Country (2027-2032) & (USD/unit) Table 152. Germany Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 153. France Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 154. U.K. Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 155. Italy Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 156. Russia Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 157. Spain Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 159. Switzerland Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 160. Sweden Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 161. Poland Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 162. China Cancer Biopsy Instruments and Kits Revenue by Type (2021-2026) & (US$ Million) Table 163. China Cancer Biopsy Instruments and Kits Revenue by Type (2027-2032) & (US$ Million) Table 164. China Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 165. China Cancer Biopsy Instruments and Kits Sales by Type (2027-2032) & (k units) Table 166. China Cancer Biopsy Instruments and Kits Sales Price by Type (2021-2026) & (USD/unit) Table 167. China Cancer Biopsy Instruments and Kits Sales Price by Type (2027-2032) & (USD/unit) Table 168. China Cancer Biopsy Instruments and Kits Revenue by Application (2021-2026) & (US$ Million) Table 169. China Cancer Biopsy Instruments and Kits Revenue by Application (2027-2032) & (US$ Million) Table 170. China Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 171. China Cancer Biopsy Instruments and Kits Sales by Application (2027-2032) & (k units) Table 172. China Cancer Biopsy Instruments and Kits Sales Price by Application (2021-2026) & (USD/unit) Table 173. China Cancer Biopsy Instruments and Kits Sales Price by Application (2027-2032) & (USD/unit) Table 174. Asia Cancer Biopsy Instruments and Kits Revenue by Type (2021-2026) & (US$ Million) Table 175. Asia Cancer Biopsy Instruments and Kits Revenue by Type (2027-2032) & (US$ Million) Table 176. Asia Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 177. Asia Cancer Biopsy Instruments and Kits Sales by Type (2027-2032) & (k units) Table 178. Asia Cancer Biopsy Instruments and Kits Sales Price by Type (2021-2026) & (USD/unit) Table 179. Asia Cancer Biopsy Instruments and Kits Sales Price by Type (2027-2032) & (USD/unit) Table 180. Asia Cancer Biopsy Instruments and Kits Revenue by Application (2021-2026) & (US$ Million) Table 181. Asia Cancer Biopsy Instruments and Kits Revenue by Application (2027-2032) & (US$ Million) Table 182. Asia Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 183. Asia Cancer Biopsy Instruments and Kits Sales by Application (2027-2032) & (k units) Table 184. Asia Cancer Biopsy Instruments and Kits Sales Price by Application (2021-2026) & (USD/unit) Table 185. Asia Cancer Biopsy Instruments and Kits Sales Price by Application (2027-2032) & (USD/unit) Table 186. Asia Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Asia Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Asia Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Asia Cancer Biopsy Instruments and Kits Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 190. Asia Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 191. Asia Cancer Biopsy Instruments and Kits Sales by Country (2027-2032) & (k units) Table 192. Asia Cancer Biopsy Instruments and Kits Sales Price by Country (2021-2026) & (USD/unit) Table 193. Asia Cancer Biopsy Instruments and Kits Sales Price by Country (2027-2032) & (USD/unit) Table 194. Japan Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 195. South Korea Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 196. India Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 197. Australia Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 198. Taiwan Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 199. Southeast Asia Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 200. SAMEA Cancer Biopsy Instruments and Kits Revenue by Type (2021-2026) & (US$ Million) Table 201. SAMEA Cancer Biopsy Instruments and Kits Revenue by Type (2027-2032) & (US$ Million) Table 202. SAMEA Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 203. SAMEA Cancer Biopsy Instruments and Kits Sales by Type (2027-2032) & (k units) Table 204. SAMEA Cancer Biopsy Instruments and Kits Sales Price by Type (2021-2026) & (USD/unit) Table 205. SAMEA Cancer Biopsy Instruments and Kits Sales Price by Type (2027-2032) & (USD/unit) Table 206. SAMEA Cancer Biopsy Instruments and Kits Revenue by Application (2021-2026) & (US$ Million) Table 207. SAMEA Cancer Biopsy Instruments and Kits Revenue by Application (2027-2032) & (US$ Million) Table 208. SAMEA Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 209. SAMEA Cancer Biopsy Instruments and Kits Sales by Application (2027-2032) & (k units) Table 210. SAMEA Cancer Biopsy Instruments and Kits Sales Price by Application (2021-2026) & (USD/unit) Table 211. SAMEA Cancer Biopsy Instruments and Kits Sales Price by Application (2027-2032) & (USD/unit) Table 212. SAMEA Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. SAMEA Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. SAMEA Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. SAMEA Cancer Biopsy Instruments and Kits Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 216. SAMEA Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 217. SAMEA Cancer Biopsy Instruments and Kits Sales by Country (2027-2032) & (k units) Table 218. SAMEA Cancer Biopsy Instruments and Kits Sales Price by Country (2021-2026) & (USD/unit) Table 219. SAMEA Cancer Biopsy Instruments and Kits Sales Price by Country (2027-2032) & (USD/unit) Table 220. Brazil Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 221. Argentina Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 222. Chile Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 223. Colombia Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 224. Peru Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 225. Saudi Arabia Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 226. Israel Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 227. UAE Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 228. Turkey Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 229. Iran Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 230. Egypt Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Table 231. Key Raw Materials Table 232. Raw Materials Key Suppliers Table 233. Cancer Biopsy Instruments and Kits Distributors List Table 234. Cancer Biopsy Instruments and Kits Customers List Table 235. Research Programs/Design for This Report Table 236. Authors List of This Report Table 237. Secondary Sources Table 238. Primary Sources List of Figures Figure 1. Cancer Biopsy Instruments and Kits Image Figure 2. Global Cancer Biopsy Instruments and Kits Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Biopsy Instruments and Kits Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cancer Biopsy Instruments Image Figure 5. Cancer Biopsy Kits Image Figure 6. Global Cancer Biopsy Instruments and Kits Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cancer Biopsy Instruments and Kits Market Size Share 2021 VS 2025 VS 2032 Figure 8. Breast Cancer Image Figure 9. Colorectal Cancer Image Figure 10. Cervical Cancer Image Figure 11. Lung Cancer Image Figure 12. Others Image Figure 13. Global Cancer Biopsy Instruments and Kits Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Cancer Biopsy Instruments and Kits Revenue (2021-2032) & (US$ Million) Figure 15. Global Cancer Biopsy Instruments and Kits Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Region (2021-2032) Figure 18. Global Cancer Biopsy Instruments and Kits Sales (2021-2032) & (k units) Figure 19. Global Cancer Biopsy Instruments and Kits Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Cancer Biopsy Instruments and Kits Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Cancer Biopsy Instruments and Kits Sales YoY (2021-2032) & (k units) Figure 22. Europe Cancer Biopsy Instruments and Kits Sales YoY (2021-2032) & (k units) Figure 23. China Cancer Biopsy Instruments and Kits Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Cancer Biopsy Instruments and Kits Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Cancer Biopsy Instruments and Kits Sales YoY (2021-2032) & (k units) Figure 26. Global Cancer Biopsy Instruments and Kits Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Cancer Biopsy Instruments and Kits Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Cancer Biopsy Instruments and Kits Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2021-2032) Figure 32. Global Cancer Biopsy Instruments and Kits Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Cancer Biopsy Instruments and Kits Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2021-2032) Figure 35. Global Cancer Biopsy Instruments and Kits Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2021-2032) Figure 38. Global Cancer Biopsy Instruments and Kits Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Cancer Biopsy Instruments and Kits Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2021-2032) Figure 41. North America Cancer Biopsy Instruments and Kits Revenue Share by Type (2021-2032) Figure 42. North America Cancer Biopsy Instruments and Kits Sales Share by Type (2021-2032) Figure 43. North America Cancer Biopsy Instruments and Kits Revenue Share by Application (2021-2032) Figure 44. North America Cancer Biopsy Instruments and Kits Sales Share by Application (2021-2032) Figure 45. North America Cancer Biopsy Instruments and Kits Revenue Share by Country (2021-2032) Figure 46. North America Cancer Biopsy Instruments and Kits Sales Share by Country (2021-2032) Figure 47. Europe Cancer Biopsy Instruments and Kits Revenue Share by Type (2021-2032) Figure 48. Europe Cancer Biopsy Instruments and Kits Sales Share by Type (2021-2032) Figure 49. Europe Cancer Biopsy Instruments and Kits Revenue Share by Application (2021-2032) Figure 50. Europe Cancer Biopsy Instruments and Kits Sales Share by Application (2021-2032) Figure 51. Europe Cancer Biopsy Instruments and Kits Revenue Share by Country (2021-2032) Figure 52. Europe Cancer Biopsy Instruments and Kits Sales Share by Country (2021-2032) Figure 53. China Cancer Biopsy Instruments and Kits Revenue Share by Type (2021-2032) Figure 54. China Cancer Biopsy Instruments and Kits Sales Share by Type (2021-2032) Figure 55. China Cancer Biopsy Instruments and Kits Revenue Share by Application (2021-2032) Figure 56. China Cancer Biopsy Instruments and Kits Sales Share by Application (2021-2032) Figure 57. Asia Cancer Biopsy Instruments and Kits Revenue Share by Type (2021-2032) Figure 58. Asia Cancer Biopsy Instruments and Kits Sales Share by Type (2021-2032) Figure 59. Asia Cancer Biopsy Instruments and Kits Revenue Share by Application (2021-2032) Figure 60. Asia Cancer Biopsy Instruments and Kits Sales Share by Application (2021-2032) Figure 61. Asia Cancer Biopsy Instruments and Kits Revenue Share by Country (2021-2032) Figure 62. Asia Cancer Biopsy Instruments and Kits Sales Share by Country (2021-2032) Figure 63. SAMEA Cancer Biopsy Instruments and Kits Revenue Share by Type (2021-2032) Figure 64. SAMEA Cancer Biopsy Instruments and Kits Sales Share by Type (2021-2032) Figure 65. SAMEA Cancer Biopsy Instruments and Kits Revenue Share by Application (2021-2032) Figure 66. SAMEA Cancer Biopsy Instruments and Kits Sales Share by Application (2021-2032) Figure 67. SAMEA Cancer Biopsy Instruments and Kits Revenue Share by Country (2021-2032) Figure 68. SAMEA Cancer Biopsy Instruments and Kits Sales Share by Country (2021-2032) Figure 69. Cancer Biopsy Instruments and Kits Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Cancer Biopsy Instruments and Kits Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Cancer Biopsy Instruments
  • Cancer Biopsy Kits
Applications
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others
Companies covered
  • QIAGEN NV
  • ANGLE plc
  • Becton, Dickinson and Company
  • BIOCEPT, INC.
  • Danaher Corporation
  • Hologic, Inc.
  • Illumina, Inc.
  • Lucence Diagnostics Pte. Ltd.
  • Myriad Genetics
  • Thermo Fisher Scientific, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cancer Biopsy Instruments and Kits Market by Type
  3. 1.2.1 Global Cancer Biopsy Instruments and Kits Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cancer Biopsy Instruments
  5. 1.2.3 Cancer Biopsy Kits
  6. 1.3 Cancer Biopsy Instruments and Kits Market by Application
  7. 1.3.1 Global Cancer Biopsy Instruments and Kits Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Breast Cancer
  9. 1.3.3 Colorectal Cancer
  10. 1.3.4 Cervical Cancer
  11. 1.3.5 Lung Cancer
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Cancer Biopsy Instruments and Kits Market Dynamics
  1. 2.1 Cancer Biopsy Instruments and Kits Industry Trends
  2. 2.2 Cancer Biopsy Instruments and Kits Industry Drivers
  3. 2.3 Cancer Biopsy Instruments and Kits Industry Opportunities and Challenges
  4. 2.4 Cancer Biopsy Instruments and Kits Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Cancer Biopsy Instruments and Kits Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Cancer Biopsy Instruments and Kits Revenue by Region
  3. 3.2.1 Global Cancer Biopsy Instruments and Kits Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cancer Biopsy Instruments and Kits Revenue by Region (2021-2026)
  5. 3.2.3 Global Cancer Biopsy Instruments and Kits Revenue by Region (2027-2032)
  6. 3.2.4 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Cancer Biopsy Instruments and Kits Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Cancer Biopsy Instruments and Kits Sales by Region
  9. 3.4.1 Global Cancer Biopsy Instruments and Kits Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Cancer Biopsy Instruments and Kits Sales by Region (2021-2026)
  11. 3.4.3 Global Cancer Biopsy Instruments and Kits Sales by Region (2027-2032)
  12. 3.4.4 Global Cancer Biopsy Instruments and Kits Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Cancer Biopsy Instruments and Kits Revenue by Manufacturers
  2. 4.1.1 Global Cancer Biopsy Instruments and Kits Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Cancer Biopsy Instruments and Kits Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cancer Biopsy Instruments and Kits Sales by Manufacturers
  6. 4.2.1 Global Cancer Biopsy Instruments and Kits Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Cancer Biopsy Instruments and Kits Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Cancer Biopsy Instruments and Kits Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Cancer Biopsy Instruments and Kits Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Cancer Biopsy Instruments and Kits Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Cancer Biopsy Instruments and Kits Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Cancer Biopsy Instruments and Kits Manufacturers, Product Type & Application
  13. 4.7 Global Cancer Biopsy Instruments and Kits Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Cancer Biopsy Instruments and Kits Market CR5 and HHI
  16. 4.8.2 2025 Cancer Biopsy Instruments and Kits Tier 1, Tier 2, and Tier 3
5 Cancer Biopsy Instruments and Kits Market by Type
  1. 5.1 Global Cancer Biopsy Instruments and Kits Revenue by Type
  2. 5.1.1 Global Cancer Biopsy Instruments and Kits Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Cancer Biopsy Instruments and Kits Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Cancer Biopsy Instruments and Kits Sales by Type
  6. 5.2.1 Global Cancer Biopsy Instruments and Kits Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cancer Biopsy Instruments and Kits Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2021-2032)
  9. 5.3 Global Cancer Biopsy Instruments and Kits Price by Type
6 Cancer Biopsy Instruments and Kits Market by Application
  1. 6.1 Global Cancer Biopsy Instruments and Kits Revenue by Application
  2. 6.1.1 Global Cancer Biopsy Instruments and Kits Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Cancer Biopsy Instruments and Kits Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Cancer Biopsy Instruments and Kits Sales by Application
  6. 6.2.1 Global Cancer Biopsy Instruments and Kits Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Cancer Biopsy Instruments and Kits Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2021-2032)
  9. 6.3 Global Cancer Biopsy Instruments and Kits Price by Application
7 Company Profiles
  1. 7.1 QIAGEN NV
  2. 7.1.1 QIAGEN NV Company Information
  3. 7.1.2 QIAGEN NV Business Overview
  4. 7.1.3 QIAGEN NV Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 QIAGEN NV Cancer Biopsy Instruments and Kits Product Portfolio
  6. 7.1.5 QIAGEN NV Recent Developments
  7. 7.2 ANGLE plc
  8. 7.2.1 ANGLE plc Company Information
  9. 7.2.2 ANGLE plc Business Overview
  10. 7.2.3 ANGLE plc Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 ANGLE plc Cancer Biopsy Instruments and Kits Product Portfolio
  12. 7.2.5 ANGLE plc Recent Developments
  13. 7.3 Becton, Dickinson and Company
  14. 7.3.1 Becton, Dickinson and Company Company Information
  15. 7.3.2 Becton, Dickinson and Company Business Overview
  16. 7.3.3 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Portfolio
  18. 7.3.5 Becton, Dickinson and Company Recent Developments
  19. 7.4 BIOCEPT, INC.
  20. 7.4.1 BIOCEPT, INC. Company Information
  21. 7.4.2 BIOCEPT, INC. Business Overview
  22. 7.4.3 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Portfolio
  24. 7.4.5 BIOCEPT, INC. Recent Developments
  25. 7.5 Danaher Corporation
  26. 7.5.1 Danaher Corporation Company Information
  27. 7.5.2 Danaher Corporation Business Overview
  28. 7.5.3 Danaher Corporation Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Danaher Corporation Cancer Biopsy Instruments and Kits Product Portfolio
  30. 7.5.5 Danaher Corporation Recent Developments
  31. 7.6 Hologic, Inc.
  32. 7.6.1 Hologic, Inc. Company Information
  33. 7.6.2 Hologic, Inc. Business Overview
  34. 7.6.3 Hologic, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hologic, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
  36. 7.6.5 Hologic, Inc. Recent Developments
  37. 7.7 Illumina, Inc.
  38. 7.7.1 Illumina, Inc. Company Information
  39. 7.7.2 Illumina, Inc. Business Overview
  40. 7.7.3 Illumina, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Illumina, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
  42. 7.7.5 Illumina, Inc. Recent Developments
  43. 7.8 Lucence Diagnostics Pte. Ltd.
  44. 7.8.1 Lucence Diagnostics Pte. Ltd. Company Information
  45. 7.8.2 Lucence Diagnostics Pte. Ltd. Business Overview
  46. 7.8.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Portfolio
  48. 7.8.5 Lucence Diagnostics Pte. Ltd. Recent Developments
  49. 7.9 Myriad Genetics
  50. 7.9.1 Myriad Genetics Company Information
  51. 7.9.2 Myriad Genetics Business Overview
  52. 7.9.3 Myriad Genetics Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Myriad Genetics Cancer Biopsy Instruments and Kits Product Portfolio
  54. 7.9.5 Myriad Genetics Recent Developments
  55. 7.10 Thermo Fisher Scientific, Inc.
  56. 7.10.1 Thermo Fisher Scientific, Inc. Company Information
  57. 7.10.2 Thermo Fisher Scientific, Inc. Business Overview
  58. 7.10.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
  60. 7.10.5 Thermo Fisher Scientific, Inc. Recent Developments
8 North America
  1. 8.1 North America Cancer Biopsy Instruments and Kits Market Size by Type
  2. 8.1.1 North America Cancer Biopsy Instruments and Kits Revenue by Type (2021-2032)
  3. 8.1.2 North America Cancer Biopsy Instruments and Kits Sales by Type (2021-2032)
  4. 8.1.3 North America Cancer Biopsy Instruments and Kits Price by Type (2021-2032)
  5. 8.2 North America Cancer Biopsy Instruments and Kits Market Size by Application
  6. 8.2.1 North America Cancer Biopsy Instruments and Kits Revenue by Application (2021-2032)
  7. 8.2.2 North America Cancer Biopsy Instruments and Kits Sales by Application (2021-2032)
  8. 8.2.3 North America Cancer Biopsy Instruments and Kits Price by Application (2021-2032)
  9. 8.3 North America Cancer Biopsy Instruments and Kits Market Size by Country
  10. 8.3.1 North America Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Cancer Biopsy Instruments and Kits Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Cancer Biopsy Instruments and Kits Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Cancer Biopsy Instruments and Kits Market Size by Type
  2. 9.1.1 Europe Cancer Biopsy Instruments and Kits Revenue by Type (2021-2032)
  3. 9.1.2 Europe Cancer Biopsy Instruments and Kits Sales by Type (2021-2032)
  4. 9.1.3 Europe Cancer Biopsy Instruments and Kits Price by Type (2021-2032)
  5. 9.2 Europe Cancer Biopsy Instruments and Kits Market Size by Application
  6. 9.2.1 Europe Cancer Biopsy Instruments and Kits Revenue by Application (2021-2032)
  7. 9.2.2 Europe Cancer Biopsy Instruments and Kits Sales by Application (2021-2032)
  8. 9.2.3 Europe Cancer Biopsy Instruments and Kits Price by Application (2021-2032)
  9. 9.3 Europe Cancer Biopsy Instruments and Kits Market Size by Country
  10. 9.3.1 Europe Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Cancer Biopsy Instruments and Kits Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Cancer Biopsy Instruments and Kits Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Cancer Biopsy Instruments and Kits Market Size by Type
  2. 10.1.1 China Cancer Biopsy Instruments and Kits Revenue by Type (2021-2032)
  3. 10.1.2 China Cancer Biopsy Instruments and Kits Sales by Type (2021-2032)
  4. 10.1.3 China Cancer Biopsy Instruments and Kits Price by Type (2021-2032)
  5. 10.2 China Cancer Biopsy Instruments and Kits Market Size by Application
  6. 10.2.1 China Cancer Biopsy Instruments and Kits Revenue by Application (2021-2032)
  7. 10.2.2 China Cancer Biopsy Instruments and Kits Sales by Application (2021-2032)
  8. 10.2.3 China Cancer Biopsy Instruments and Kits Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cancer Biopsy Instruments and Kits Market Size by Type
  2. 11.1.1 Asia Cancer Biopsy Instruments and Kits Revenue by Type (2021-2032)
  3. 11.1.2 Asia Cancer Biopsy Instruments and Kits Sales by Type (2021-2032)
  4. 11.1.3 Asia Cancer Biopsy Instruments and Kits Price by Type (2021-2032)
  5. 11.2 Asia Cancer Biopsy Instruments and Kits Market Size by Application
  6. 11.2.1 Asia Cancer Biopsy Instruments and Kits Revenue by Application (2021-2032)
  7. 11.2.2 Asia Cancer Biopsy Instruments and Kits Sales by Application (2021-2032)
  8. 11.2.3 Asia Cancer Biopsy Instruments and Kits Price by Application (2021-2032)
  9. 11.3 Asia Cancer Biopsy Instruments and Kits Market Size by Country
  10. 11.3.1 Asia Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Cancer Biopsy Instruments and Kits Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Cancer Biopsy Instruments and Kits Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cancer Biopsy Instruments and Kits Market Size by Type
  2. 12.1.1 SAMEA Cancer Biopsy Instruments and Kits Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Cancer Biopsy Instruments and Kits Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Cancer Biopsy Instruments and Kits Price by Type (2021-2032)
  5. 12.2 SAMEA Cancer Biopsy Instruments and Kits Market Size by Application
  6. 12.2.1 SAMEA Cancer Biopsy Instruments and Kits Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Cancer Biopsy Instruments and Kits Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Cancer Biopsy Instruments and Kits Price by Application (2021-2032)
  9. 12.3 SAMEA Cancer Biopsy Instruments and Kits Market Size by Country
  10. 12.3.1 SAMEA Cancer Biopsy Instruments and Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Cancer Biopsy Instruments and Kits Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Cancer Biopsy Instruments and Kits Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Cancer Biopsy Instruments and Kits Value Chain Analysis
  2. 13.1.1 Cancer Biopsy Instruments and Kits Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Cancer Biopsy Instruments and Kits Production Mode & Process
  6. 13.2 Cancer Biopsy Instruments and Kits Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Cancer Biopsy Instruments and Kits Distributors
  9. 13.2.3 Cancer Biopsy Instruments and Kits Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst